Science
Mechanism of Action
This lipo-peptide operates through a precise dual mechanism. Primarily, it stimulates the Transforming Growth Factor-beta (TGF-β) pathway, which upregulates fibroblast activity to produce essential structural proteins like collagen and elastin. Concurrently, its lipophilic elaidic acid component strategically inhibits and downregulates various metalloproteinase enzymes (MMP-1, MMP-2, MMP-3, and MMP-9) responsible for breaking down collagen and other extracellular matrix components. This combined action boosts skin repair processes, reinforcing the extracellular matrix for improved skin suppleness and firmness.
Research
Clinical Evidence
Medium confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
The lipophilic nature, attributed to its elaidic acid component, may facilitate enhanced skin absorption due to its compatibility with the skin's natural lipid membrane. As a peptide, it is generally susceptible to degradation when exposed to extreme pH conditions, requiring careful formulation within a balanced pH range.
Conflicts
- Retinoids (due to general peptide instability)
- Hydroxy acids (due to general peptide instability)
Safety
Safety Profile
Direct safety assessments from CIR, SCCS, or FDA for Elaidoyl Tripeptide-37 are currently unavailable. However, the CIR Expert Panel has generally deemed related tripeptides and their fatty acyl derivatives safe, typically at concentrations below 10 ppm. Its analog, Palmitoyl Tripeptide-37, is widely regarded as safe and non-irritating for most skin types at standard doses.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Elaidoyl Tripeptide-37 presents as a valuable ingredient for advanced anti-aging formulations, leveraging a clear mechanism to boost collagen and elastin while protecting against their degradation, suitable for all skin types despite limited specific regulatory data.
Related
Similar Ingredients
Finding similar ingredients…